Forbes June 20, 2024
Arianna Johnson

Topline

Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli Lilly for allegedly selling compounded and counterfeit versions of ultra-popular weight loss and diabetes drugs Mounjaro and Zepbound, a problem also raised by Ozempic maker Novo Nordisk—and health organizations warn these products may pose serious side effects like infections.

Key Facts

How To Tell If Your Weight Loss Drugs Are Fake

There are several ways to spot fake GLP-1 drugs. Lilly noted some fake versions of its products have a pink hue instead of being colorless like the official products. If the product is labeled as generic tirzepatide or semaglutide then it’s fake because neither Lilly nor Novo Nordisk sells generic versions of its drugs. Another...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma / Biotech
Related Articles:
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
FDA approves 1st RSV vaccine for adults under 60
Lawmakers seek answers on Pfizer, Lilly telehealth moves
Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs?
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

Share This Article